Controversial Alzheimer's drug approval sparks surprising impact
When the U.S. Food and Drug Administration gave controversial accelerated approval to the first Alzheimer's drug in nearly 20 years, it had a surprising impact on attitudes about research into the disease. A survey by University ...
Nov 30, 2022
0
2
